About the Counter Team: Counter (Macrofy Inc) was founded in 2022 by Counter Team
GLP-1 medications work through several complementary mechanisms: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps lower blood sugar levels Suppressing glucagon release , thereby reducing hepatic glucose production Slowing gastric emptying , which prolongs satiety and reduces appetite Acting on appetite centres in the brain , leading to reduced caloric intake and weight loss Commonly prescribed GLP-1 receptor agonists available in the UK include semaglutide (Ozempic, Wegovy, Rybelsus [oral form]), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and exenatide (Byetta, Bydureon)
Only about one in seven women successfully lose this amount of weight and keep it off
Maintain at least four weeks between dose adjustments to reduce the risk of side effects
I have sat on two NHS England policy working groups looking at diagnostic pathways and delivery issues relating to lecanemab treatment for Alzheimers Disease